Objective: To determine if atomoxetine would improve attention impairment following traumatic brain injury (TBI).
Setting: Outpatients from a free-standing, private, not-for-profit rehabilitation hospital.
Population: Fifty-five adult participants with a history of a single moderate-to-severe TBI, who were at least 1 year from injury and with self-reported complaints of attention difficulties.
Objective: To evaluate the efficacy of a replicable group treatment program to improve social communication skills after traumatic brain injury (TBI).
Design: Randomized treatment and deferred treatment controlled trial, with follow-up at 3, 6, and 9 months post-treatment.
Setting: Community.
Primary Objective: To investigate the effectiveness of donepezil hydrochloride (Aricept) in treating persistent memory deficits in people with traumatic brain injury.
Research Design: Single subject ABAC design was used so that each participant could serve as their own control.
Methods And Procedures: Seven TBI survivors with persistent memory dysfunction, at least 1.